Company Overview
- Website
- cerevance.com
- Employees
- 1
- Founded in
- 2016
- Industry
- BioTech/Drugs
- SIC Code
-
2834 - Pharmaceutical Preparations
Financials & Stats
Revenue
$50B
Recent News & Media
A First-in-Human Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN293, an Investigational Inhibitor of KCNK13 Targeting NLRP3-Mediated Neuroinflammation (P8-3.016)
- Apr 8, 2025
- pubmed.ncbi.nlm.nih.gov
Cerevance Presents Positive Results from Phase 1 Study of
- Apr 8, 2025
- globenewswire.com
Solengepras (CVN424): A Novel GPR6 Inhibitor in Clinical Development as an Investigational Therapy for Parkinson’s Disease (P11-5.017)
- Apr 7, 2025
- neurology.org
Cerevance Presents Topline Results from Phase 2 ASCEND
- Apr 1, 2025
- globenewswire.com
Disruptive Psychopharmacology
- Nov 19, 2024
- pmc.ncbi.nlm.nih.gov
Cerevance describes new CD38 inhibitors
- Dec 22, 2023
- bioworld.com
Who is Cerevance Inc
Cerevance Inc. is a privately held company headquartered in Boston, Massachusetts. The company is a small business with one employee. Cerevance focuses on the development of novel therapies for neurological disorders. Their research efforts concentrate on treating diseases like Alzheimer's disease. Cerevance distinguishes itself through its commitment to developing treatments that target specific pathways involved in neurodegeneration. They utilize a comprehensive approach, combining cutting-edge research with clinical expertise to advance promising therapies to patients. For more information about Cerevance Inc. and their innovative work, visit their website at cerevance.com.
Company Leadership
Companies Similar to Cerevance Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Cerevance Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
50M | Waltham, MA | |||
50M | 105 | Durham, NC | ||
50M | 32 | Dallas, TX | ||
50M | 49 | New York, NY | ||
50M | 33 | Chattanooga, TN |